Allarity Therapeutics, Inc. (ALLR) Tops Q1 EPS by 763c

Allarity Therapeutics, Inc. (NASDAQ: ALLR) reported Q1 EPS of ($0.25), $7.63 better than the analyst estimate of ($7.88).

For earnings history and earnings-related data on Allarity Therapeutics, Inc. (ALLR) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• SPS Commerce hires Morgan Stanley, explores sale - Reuters
• Zuckerberg Directed Meta To Create Prediction Markets App - NYT